Why are U.S. COVID-19 vaccines still out of reach in India?

How is the indemnity clause issue being handled? What are the manufacturers saying? Does this affect the pricing and availability of doses in India?

: More than six months after the government announced it would fast-track clearances for foreign COVID-19 vaccines to India, the indemnity clause is still holding up the import of all American vaccines to India, including those manufactured by Pfizer, Johnson & Johnson and Moderna. Without specifying a timeline, a senior Health Ministry official said talks are on and that the “indemnity clause is also being discussed.”

Indemnity is a form of contract. It is not specifically provided for in any law or regulation related to the grant of approval for any new drug or vaccine in the country. If it all any indemnity is to be granted to any company in respect of a particular drug or vaccine, it can only be in the form of an indemnity bond executed on behalf of the government of India, or a clause or set of clauses in any contract that the government may sign with the supplier. There appears to be no precedent for any company getting such indemnity in India for any drug.